Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST C-C chemokine receptor type 2 antagonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pulmonary Disease, Chronic Obstructive 2 D029424 ClinicalTrials
Neuralgia 2 D009437 ClinicalTrials
Pain 2 D010146 ClinicalTrials
Lung Diseases 2 D008171 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3545221